QLGN - Qualigen Therapeutics EPS beats by $0.11 misses on revenue November, 15 2021 09:10 AM Qualigen Therapeutics Inc. Qualigen Therapeutics (NASDAQ:QLGN): Q3 GAAP EPS of -$0.10 beats by $0.11. Revenue of $1.16M (+38.1% Y/Y) misses by $0.18M. Press Release For further details see: Qualigen Therapeutics EPS beats by $0.11, misses on revenue